ICLR Stock - ICON Public Limited Company
Unlock GoAI Insights for ICLR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $8.28B | $8.12B | $7.74B | $5.48B | $2.80B |
| Gross Profit | $2.44B | $2.40B | $2.21B | $1.51B | $808.03M |
| Gross Margin | 29.4% | 29.6% | 28.6% | 27.5% | 28.9% |
| Operating Income | $1.10B | $956.15M | $795.24M | $378.53M | $391.50M |
| Net Income | $791.47M | $612.34M | $505.30M | $153.19M | $327.81M |
| Net Margin | 9.6% | 7.5% | 6.5% | 2.8% | 11.7% |
| EPS | $9.60 | $7.46 | $6.20 | $2.28 | $6.29 |
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Visit WebsiteEarnings History & Surprises
ICLREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 18, 2026 | $3.32 | — | — | — |
Q4 2025 | Oct 22, 2025 | $3.28 | $3.31 | +0.9% | ✓ BEAT |
Q3 2025 | Jul 23, 2025 | $3.19 | $3.26 | +2.2% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $3.11 | $3.19 | +2.6% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $3.41 | $3.43 | +0.6% | ✓ BEAT |
Q4 2024 | Oct 23, 2024 | $3.85 | $3.35 | -13.0% | ✗ MISS |
Q3 2024 | Jul 24, 2024 | $3.68 | $3.75 | +1.9% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $3.41 | $3.47 | +1.8% | ✓ BEAT |
Q1 2024 | Feb 21, 2024 | $3.44 | $3.46 | +0.6% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $3.28 | $3.30 | +0.6% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $3.08 | $3.11 | +1.0% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $2.98 | $2.90 | -2.7% | ✗ MISS |
Q1 2023 | Feb 22, 2023 | $3.06 | $3.13 | +2.3% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $2.93 | $3.00 | +2.4% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $2.79 | $2.86 | +2.5% | ✓ BEAT |
Q2 2022 | Apr 27, 2022 | $2.71 | $2.76 | +1.8% | ✓ BEAT |
Q1 2022 | Feb 22, 2022 | $2.63 | $2.63 | 0.0% | = MET |
Q4 2021 | Nov 3, 2021 | $2.43 | $2.55 | +4.9% | ✓ BEAT |
Q3 2021 | Jul 21, 2021 | $2.10 | $2.12 | +1.0% | ✓ BEAT |
Latest News
Frequently Asked Questions about ICLR
What is ICLR's current stock price?
What is the analyst price target for ICLR?
What sector is ICON Public Limited Company in?
What is ICLR's market cap?
Does ICLR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ICLR for comparison